Silicone granulomas following free silicone gluteal augmentation Brian Wosnitzer, MD, and Rosna Mirtcheva, MD Gallium-67 citrate has long been used for imaging of infection and inflammation. Although gallium-67 uptake due to silicone implants and silicone injections has been previously reported in the literature, very few cases are documented. We report a case of increased gallium-67 uptake in the buttocks in a patient who previously received silicone injections in the buttocks, to reemphasize silicone augmentation as a potential source of gallium-67 uptake. In addition, we present a F-18-fluorodeoxyglucose (FDG) PET/ CT scan from the same patient to demonstrate mild diffuse FDG uptake in the buttocks in the region of previous silicone injection. Although FDG is well known to accumulate in areas of inflammation such as prior sites of silicone injection or silicone implantation in the breast, FDG uptake in the buttocks due to silicone injections has not been previously reported or correlated with a gallium scan. silicone implants as a potential cause of increased gallium-67 uptake. In addition, we correlate our patient's gallium scan with a F-18-fluorodeoxyglucose (FDG) PET/CT to emphasize that increased FDG uptake may also be seen in the setting of prior silicone injections in the buttocks or elsewhere in the body. Because previous case reports demonstrating Ga-67 uptake due to silicone injections in the buttocks were published before the clinical use of PET/CT, correlation with PET/CT was not available at that time (8) (9) (10) .
Gallium-67 citrate has long been used for imaging of infection and inflammation. The mechanism of gallium uptake at the inflammatory site of prior silicone injections is well understood. Although potential causes of inflammation are numerous, the mechanism of gallium localization to sites of inflammation usually relies on locally increased blood flow and increased vascular permeability at sites of inflammation, regardless of the cause. An additional factor that promotes Ga-67 localization to regions of inflammation is its ferric-ion-like properties. Ga-67 has a high affinity for and binds to lactoferrin, which is released by leukocytes at inflammatory sites (11, 12) .
In our patient, the diffuse, bilateral Ga-67 uptake in the gluteal area led us to suspect silicone injections as a cause of Ga-67 uptake. In addition, absence of local signs such as erythema or pain argued against an acute infectious process such as phlegmon or abscess formation. Other causes of increased gallium uptake such as lymphoma were also unlikely due to the location and diffuse, symmetric tracer uptake (11, 12) .
In addition to causing increased tracer uptake on gallium scan, it is well known that the inflammatory granulomatous response following silicone injections can cause increased FDG uptake on PET/CT (10) (11) (12) . Previous studies have shown that SUVs may vary greatly in the setting of inflammation and can be very high (5, 11, 12) . The most important concept for physicians to recognize is that focally increased FDG uptake at the site of prior silicone injections may cause false-positive results by mimicking tumor (10) . This is particularly important in the breast (10) . FDG uptake in the breast after silicone implant or injection may mimic a new primary breast tumor, recurrent breast tumor in a patient with previous disease, or positive lymph nodes (10, 13) . Migration of silicone into the lymphatics after injection can also cause false-positive interpretation at sites that are remote from the initial silicone injection site (10, 13, 14) . With regard to subcutaneous silicone injection in the buttocks, diffuse symmetric FDG uptake in the gluteal area has to be differentiated from exercise-or insulin-related muscle uptake, which usually involves multiple muscle groups. In addition, focally increased FDG uptake in the buttocks may be mistaken for sarcoma, connective-tissue tumor, or abscess (11, 12) .
An additional point is the patient population where silicone injections in the hips and in the gluteal area have previously been reported. Some of the previous reports of silicone injection for breast, hip, or gluteal augmentation were in transgender patients undergoing male-to-female sex change (7) . Focused patient history related to the scan findings may explain causes of increased radiotracer uptake on gallium scan or FDG PET/CT. Frequently, the patients may be reluctant to reveal this history (15) .
Lastly, we would like to address the persistence of increased tracer uptake on gallium and FDG PET/CT scan Silicone granulomas following free silicone gluteal augmentation RCR Radiology Case Reports | radiology.casereports.net for many years after silicone injection. Our case report and prior case reports have demonstrated increased Ga-67 uptake up to ten years following silicone injections (8, 9) . As per Ho et al., granulomatous reactions may occur from three weeks to twenty years after silicone injection (10) . Therefore we can conclude that the increased Ga-67 and FDG uptake due to silicone injections can be visualized for at least ten years and perhaps longer (8) .
In conclusion, we report this case to emphasize that silicone injections are a potential cause of increased radiotracer uptake on gallium scans and FDG PET/CT. Such knowledge will prevent false-positive and false-negative scan interpretation (5) . In addition, we stress that silicone injections are frequently seen in transsexual patients as well in other patients who have sought to augment their physical appearance (3). Lastly, we reiterate that diffuse and/or symmetrical radiotracer uptake on gallium or PET/CT without clinical evidence of infection favors a granulomatous response ("siliconoma") in the presence of a history of silicone injection. . 48-year-old HIV-positive male with silicone granulomas. Anterior (left) and posterior (right) projections from gallium scan acquired 48 hours after the intravenous administration of 6.1 mCi of gallium-67 citrate demonstrate physiologic tracer uptake in the chest without evidence of PCP. In addition, there is moderate diffuse tracer uptake in the gluteal area bilaterally (arrows). Focal tracer concentration in the left pelvis that resolved on followup imaging (Fig. 4) is consistent with physiologic excretion of tracer in the bowel (arrow).
